Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
F
Details...
Enter Symbol
Pharmaceutical Resources, Inc. (NYSE: PRX)
Sector: Medical
Current Price :
$49.98
52 Week Low
$26.11
52 Week High
$50.19
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
36M
Market Cap:
$1.84B
Avg Volume:
646405
P/E Ratio:
12.620
PEG Ratio:
1.990
Split:
On 3/12/1987 prx split by factor of 1.500
1m
3m
6m
1y
2y
Opinion and Analysis
AstraZeneca (AZN) Receives Favorable Patent Appeal Ruling For Cholesterol Drug Crestor
Dec 14, 2012 02:31 PM |
AZN
,
MYL
,
PRX
,
TEVA
UBS Downgrades Par Pharmaceutical (PRX) To 'Neutral', Says Lower Possibility Of Another Bid
Aug 08, 2012 01:02 PM |
PRX
Stocks Retreat As Retail Sales Data, Earnings Weigh
Jul 16, 2012 04:20 PM |
ANR
,
BAC
,
C
,
GCI
,
GE
,
GOOG
More Articles on PRX..
Press Releases
Par Announces Completion Of Acquisition By TPG
Sep 28, 2012 11:40 AM |
PRX
ADT, Pentair Set to Join the S&P 500; Lexmark, DeVry to Join the S&P MidCap 400 and MarketAxess to Join the S&P SmallCap 600
Sep 24, 2012 06:01 PM |
DV
,
LXK
,
MHP
,
MKTX
,
PNR
,
PRX
Par Pharmaceutical Companies Announces The Expiration Of The "Go Shop" Period, Receipt Of Early Termination Of HSR Waiting Period And Special Meeting Date
Aug 27, 2012 08:00 AM |
PRX
More Press Releases on PRX..
SEC Filings
Form 4 PAR PHARMACEUTICAL COMPA For: Sep 28 Filed by: SMITH JOSEPH E (10K)
Oct 02, 2012 06:34 PM
Form 4 PAR PHARMACEUTICAL COMPA For: Sep 28 Filed by: KNIGHT PETER S (10K)
Oct 02, 2012 06:21 PM
Form 4 PAR PHARMACEUTICAL COMPA For: Sep 28 Filed by: NORDMANN RONALD M (10K)
Oct 02, 2012 06:07 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
PRX
Compare to S&P
YTD
52.70 %
33.30 %
4 Weeks
0.36 %
-2.01 %
12 Weeks
40.39 %
32.01 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
97.56 %
EPS Growth in Last Year:
92.86 %
Sales Growth in Last Quarter:
8.42 %
Sales Growth in Last Quarter:
31.29 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##